HEARTBEAM, INC. (BEAT) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$5.09M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$4.72M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$5.29M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$5.04M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$5.09M | (m) | (m) | (m) | $249.00K* | -$3.34M* | (m) | $2.33M | (m) | $0.00 |
| 2026-03-31 | Reported | (m) | -$4.72M | (m) | (m) | (m) | $246.00K | -$3.61M | (m) | $2.37M | (m) | $0.00 |
| 2025-09-30 | Reported | (m) | -$5.29M | (m) | (m) | (m) | $82.00K* | -$3.16M* | (m) | $3.28M | (m) | $0.00 |
| 2025-06-30 | Reported | (m) | -$5.04M | (m) | (m) | (m) | $102.00K* | -$3.44M* | (m) | $3.33M | (m) | $0.00 |
| 2025-03-31 | Reported | (m) | -$5.50M | (m) | (m) | (m) | $0.00 | -$4.48M | (m) | $3.49M | (m) | $0.00 |
| 2024-09-30 | Reported | (m) | -$5.07M | (m) | (m) | (m) | $103.00K* | -$3.31M* | (m) | $2.89M | (m) | $0.00 |
| 2024-06-30 | Reported | (m) | -$5.09M | (m) | (m) | (m) | $10.00K* | -$3.55M* | (m) | $2.84M | (m) | $0.00 |
| 2024-03-31 | Reported | (m) | -$4.78M | (m) | (m) | (m) | $88.00K | -$3.46M | (m) | $2.43M | (m) | $0.00 |
| 2023-09-30 | Reported | (m) | -$3.74M | (m) | (m) | (m) | $144.00K* | -$2.10M* | (m) | $1.62M | (m) | $0.00 |
| 2023-06-30 | Reported | (m) | -$3.31M | (m) | (m) | (m) | $0.00* | -$4.02M* | (m) | $1.48M | (m) | $0.00 |
| 2023-03-31 | Reported | (m) | -$4.16M | (m) | (m) | (m) | $0.00 | -$3.11M | (m) | $1.68M | (m) | $0.00 |
| 2022-09-30 | Reported | (m) | -$3.61M | (m) | (m) | (m) | (m) | -$2.73M* | (m) | $1.56M | (m) | $0.00 |
| 2022-06-30 | Reported | (m) | -$3.54M | (m) | (m) | (m) | (m) | -$1.93M* | (m) | $1.74M | (m) | $0.00 |
| 2022-03-31 | Reported | (m) | -$2.15M | (m) | (m) | (m) | (m) | -$2.34M | (m) | $734.00K | (m) | $0.00 |
| 2021-09-30 | Reported | (m) | -$446.00K | (m) | (m) | (m) | (m) | -$365.00K* | (m) | $105.00K | $341.00K | $0.00 |
| 2021-06-30 | Reported | (m) | -$337.00K | (m) | (m) | (m) | (m) | -$269.00K* | (m) | $25.00K | (m) | $0.00 |
| 2021-03-31 | Reported | (m) | -$163.00K | (m) | (m) | (m) | (m) | -$155.00K | (m) | $29.00K | (m) | $0.00 |
| 2020-09-30 | Reported | (m) | -$272.00K | (m) | (m) | (m) | (m) | (m) | (m) | $57.00K | $215.00K | $0.00 |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$21.14M | (m) | (m) | (m) | $600.00K | -$13.99M | (m) | $13.45M | (m) | $0.00 |
| 2024-12-31 | Reported | (m) | -$19.89M | (m) | (m) | (m) | $201.00K | -$14.47M | (m) | $11.05M | (m) | $0.00 |
| 2023-12-31 | Reported | (m) | -$15.31M | (m) | (m) | (m) | $256.00K | -$12.09M | (m) | $6.80M | (m) | $0.00 |
| 2022-12-31 | Reported | (m) | -$13.03M | (m) | (m) | (m) | $0.00 | -$9.95M | (m) | $5.68M | (m) | $0.00 |
| 2021-12-31 | Reported | (m) | -$2.29M | (m) | (m) | (m) | (m) | -$3.23M | (m) | $255.00K | (m) | $0.00 |
| 2020-12-31 | Reported | (m) | -$788.00K | (m) | (m) | (m) | (m) | -$600.00K | (m) | $133.00K | (m) | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |